Tuberculosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 12 years old or older
- You have finished a standard 6-month course of tuberculosis (TB) treatment, which included four specific medicines: isoniazid, rifampin, pyrazinamide, and ethambutol
Who may not be able to join:
- You finished your TB treatment more than 14 days before the screening or enrollment date
- You have regularly taken any medication in the last 14 days that fights certain types of bacteria (including a type of antibiotic called fluoroquinolones) for any reason unrelated to TB treatment
- You are unwilling to give your consent to participate or are unable to come back for follow-up visits during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Adithya Cattamanchi, MD, University of California San Francisco; University of California Irvine
Phone: 415-206-5489
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recurrent tuberculosis (TB); Prognostic accuracy of novel biomarkers in predicting recurrent TB
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.